These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1949966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interpreting drug levels.
    Cridland JS.
    S Afr Med J; 1985 Mar 16; 67(11):401-2. PubMed ID: 3983717
    [Abstract] [Full Text] [Related]

  • 3. The 1978 College of American Pathologists Therapeutic Drug Monitoring Interlaboratory Survey Program.
    Juel R.
    Am J Clin Pathol; 1979 Aug 16; 72(2 Suppl):306-19. PubMed ID: 474507
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma concentrations of drugs as a guide to therapy in clinical practice.
    Kelly JG, O'Malley K.
    Ir Med J; 1978 Nov 30; 71(17):578-82. PubMed ID: 721412
    [No Abstract] [Full Text] [Related]

  • 6. Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer.
    Oeltgen PR, Shank WA, Blouin RA, Clark T.
    Ther Drug Monit; 1984 Nov 30; 6(3):360-7. PubMed ID: 6390799
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of CAVH membrane types on drug-sieving coefficients and clearances.
    Kronfol NO, Lau AH, Colon-Rivera J, Libertin CL.
    ASAIO Trans; 1986 Nov 30; 32(1):85-7. PubMed ID: 3096363
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug interferences with plasma assays in therapeutic drug monitoring.
    Yosselson-Superstine S.
    Clin Pharmacokinet; 1984 Nov 30; 9(1):67-87. PubMed ID: 6362953
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of evacuated blood-collection tubes: effects of three types of polymeric separators on therapeutic drug-monitoring specimens.
    Landt M, Smith CH, Hortin GL.
    Clin Chem; 1993 Aug 30; 39(8):1712-7. PubMed ID: 8353961
    [Abstract] [Full Text] [Related]

  • 13. Comparable effects of DIGIBIND and DigiFab in thirteen digoxin immunoassays.
    McMillin GA, Owen WE, Lambert TL, De BK, Frank EL, Bach PR, Annesley TM, Roberts WL.
    Clin Chem; 2002 Sep 30; 48(9):1580-4. PubMed ID: 12194938
    [No Abstract] [Full Text] [Related]

  • 14. Digoxin and Phenytoin analyses as part of consultations in clinical pharmacology: a study on the use of drugs.
    Bergman U, Rane A, Sjöqvist F, Wiholm BE.
    Ther Drug Monit; 1981 Sep 30; 3(3):259-69. PubMed ID: 7324090
    [Abstract] [Full Text] [Related]

  • 15. Serum digoxin concentrations and clinical signs and symptoms of digoxin toxicity in the paediatric population.
    Moffett BS, Garner A, Zapata T, Orcutt J, Niu M, Lopez KN.
    Cardiol Young; 2016 Mar 30; 26(3):493-8. PubMed ID: 25912244
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical pharmacokinetics: the pharmacological monitoring of plasmatic levels in therapy.
    Bonora MR, Guaglio R, Terzoni PA, Rondanelli R.
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar 30; 18(2):73-87. PubMed ID: 7372379
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.